129 related articles for article (PubMed ID: 12955623)
21. [First Hungarian report of olopatadine eyedrop therapy in children and adults suffering from seasonal allergic conjunctivitis].
Endre L; Hidasi V
Orv Hetil; 2006 Sep; 147(36):1741-3. PubMed ID: 17087018
[TBL] [Abstract][Full Text] [Related]
22. A clinicopathological analysis of the efficacy of lodoxamide 0.1% eye drops on the conjunctiva of patients with vernal keratoconjunctivitis seen at Guinness Eye Centre, Lagos University Teaching Hospital.
Adefule-Ositelu AO; Onakoya AO; Olasimbo OO; Adefule AK
Niger Postgrad Med J; 2006 Mar; 13(1):35-40. PubMed ID: 16633377
[TBL] [Abstract][Full Text] [Related]
23. [Nedocromil sodium as a topical treatment of allergic conjunctivitis due to grasses].
Pacor ML; Biasi D; Maleknia T; Carletto A; Lunardi C
Recenti Prog Med; 1996 May; 87(5):215-7. PubMed ID: 8767757
[TBL] [Abstract][Full Text] [Related]
24. Comparative efficacy of olopatadine 0.1% ophthalmic solution versus levocabastine 0.05% ophthalmic suspension using the conjunctival allergen challenge model.
Abelson MB; Greiner JV
Curr Med Res Opin; 2004 Dec; 20(12):1953-8. PubMed ID: 15701212
[TBL] [Abstract][Full Text] [Related]
25. [Evaluation of the efficacy and safety of lodoxamide in patients with allergic eye diseases].
Dekaris I; Gabrić N; Lazić R; Bosnar D; Cima I; Stipić A
Acta Med Croatica; 2002; 56(3):93-8. PubMed ID: 12630339
[TBL] [Abstract][Full Text] [Related]
26. Long-term safety of loteprednol etabonate 0.2% in the treatment of seasonal and perennial allergic conjunctivitis.
Ilyas H; Slonim CB; Braswell GR; Favetta JR; Schulman M
Eye Contact Lens; 2004 Jan; 30(1):10-3. PubMed ID: 14722462
[TBL] [Abstract][Full Text] [Related]
27. Evidence-based study design in ocular allergy trials.
Katelaris CH; Bielory L
Curr Opin Allergy Clin Immunol; 2008 Oct; 8(5):484-8. PubMed ID: 18769206
[TBL] [Abstract][Full Text] [Related]
28. Combination of omalizumab and specific immunotherapy is superior to immunotherapy in patients with seasonal allergic rhinoconjunctivitis and co-morbid seasonal allergic asthma.
Kopp MV; Hamelmann E; Zielen S; Kamin W; Bergmann KC; Sieder C; Stenglein S; Seyfried S; Wahn U;
Clin Exp Allergy; 2009 Feb; 39(2):271-9. PubMed ID: 19016798
[TBL] [Abstract][Full Text] [Related]
29. Bilastine 0.6% Preservative-free Eye Drops: A Once-daily Treatment for Allergic Conjunctivitis.
Gomes PJ; Ciolino JB; Arranz P; Hernández G; Fernández N
J Investig Allergol Clin Immunol; 2024 Jun; 34(3):167-176. PubMed ID: 36811846
[TBL] [Abstract][Full Text] [Related]
30. Effects of a new formulation of olopatadine ophthalmic solution on nasal symptoms relative to placebo in two studies involving subjects with allergic conjunctivitis or rhinoconjunctivitis.
Abelson MB; Gomes PJ; Vogelson CT; Pasquine TA; Turner FD; Wells DT; Robertson SM
Curr Med Res Opin; 2005 May; 21(5):683-91. PubMed ID: 15969867
[TBL] [Abstract][Full Text] [Related]
31. Efficacy and safety of ketotifen eye drops in the treatment of seasonal allergic conjunctivitis.
Kidd M; McKenzie SH; Steven I; Cooper C; Lanz R;
Br J Ophthalmol; 2003 Oct; 87(10):1206-11. PubMed ID: 14507747
[TBL] [Abstract][Full Text] [Related]
32. Ocular tolerability and safety of ketotifen fumarate ophthalmic solution.
Abelson MB; Chapin MJ; Kapik BM; Shams NB
Adv Ther; 2002; 19(4):161-9. PubMed ID: 12431041
[TBL] [Abstract][Full Text] [Related]
33. Comparison of 0.1% bromfenac sodium and 0.1% pemirolast potassium for the treatment of allergic conjunctivitis.
Miyake-Kashima M; Takano Y; Tanaka M; Satake Y; Kawakita T; Dogru M; Asano-Kato N; Fukagawa K; Fujishima H
Jpn J Ophthalmol; 2004; 48(6):587-90. PubMed ID: 15592786
[TBL] [Abstract][Full Text] [Related]
34. Topical tacrolimus 0.03% ointment for intractable allergic conjunctivitis: an open-label pilot study.
Attas-Fox L; Barkana Y; Iskhakov V; Rayvich S; Gerber Y; Morad Y; Avni I; Zadok D
Curr Eye Res; 2008 Jul; 33(7):545-9. PubMed ID: 18600486
[TBL] [Abstract][Full Text] [Related]
35. [Comparative study between 0.025% ketotifen fumarate and 0.1% olopatadine hydrochloride in the treatment of vernal keratoconjunctivitis].
Hida WT; Nogueira DC; Schaefer A; Dantas PE; Dantas MC
Arq Bras Oftalmol; 2006; 69(6):851-6. PubMed ID: 17273679
[TBL] [Abstract][Full Text] [Related]
36. [Efficacy of nedocromil sodium in perennial allergic conjunctivitis].
Pacor ML; Biasi D; Carletto A; Corrocher R; Lunardi C
Recenti Prog Med; 1998 Oct; 89(10):501-3. PubMed ID: 9842252
[TBL] [Abstract][Full Text] [Related]
37. Levocetirizine for the treatment of allergic rhinitis and chronic idiopathic urticaria in adults and children.
Singh-Franco D; Ghin HL; Robles GI; Borja-Hart N; Perez A
Clin Ther; 2009 Aug; 31(8):1664-87. PubMed ID: 19808127
[TBL] [Abstract][Full Text] [Related]
38. Effects of topical application of ibudilast for seasonal allergic conjunctivitis in patients wearing soft contact lenses.
Sakuma K; Toshida H; Honda R; Tanaka K; Fukazawa A; Takahashi K; Suto C; Ebihara N; Murakami A
Eye Contact Lens; 2009 Sep; 35(5):251-4. PubMed ID: 19672196
[TBL] [Abstract][Full Text] [Related]
39. Comparison of allergen immunotherapy and drug treatment in seasonal rhinoconjunctivitis: a 3-years study.
Giovannini M; Braccioni F; Sella G; Contoli M; Perri G; Frati F; Incorvaia C
Eur Ann Allergy Clin Immunol; 2005 Feb; 37(2):69-71. PubMed ID: 15859367
[TBL] [Abstract][Full Text] [Related]
40. [Evaluation of efficacy and safety of sterile solution of lodoxamide in patients with ocular allergy].
Nicoară S
Oftalmologia; 2001; 52(2):81-4. PubMed ID: 11771108
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
